Merdad Parsey's Net Worth

$14.5 Million

Estimate Recalculated Jul 1, 2024 07:08PM EST

Who is Merdad Parsey?

Merdad Parsey has an estimated net worth of $14.5 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES, INC., Sagimet Biosciences Inc., and Arcus Biosciences, Inc..

SEC CIK

Merdad Parsey's CIK is 0001792150

Past Insider Trading and Trends

2023 was Merdad Parsey's most active year for acquiring shares with 17 total transactions. Merdad Parsey's most active month to acquire stocks was the month of February. 2023 was Merdad Parsey's most active year for disposing of shares, totalling 21 transactions. Merdad Parsey's most active month to dispose stocks was the month of February. 2023 saw Merdad Parsey paying a total of $21,199.07 for 251,619 shares, this is the most they've acquired in one year. In 2024 Merdad Parsey cashed out on 23,709 shares for a total of $1,855,466.34, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GILEAD SCIENCES, INC. (GILD) Snapshot price: $74.66

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.03%
-2.00K
$68.63
-$137,260.00
96.38K
Scheduled
Jul 1
Form 4
+2.16%
2.08K
$65.25
-$113,796.00
98.38K
Jun 10
Form 4
-2.03%
-2.00K
$72.96
-$145,920.00
96.3K
Scheduled
Apr 1
Form 4
+6.04%
5.6K
$75.12
-$360,801.36
98.3K
Mar 10
Form 4
-9.94%
-10.23K
$72.82
-$744,983.86
92.71K
Scheduled
Feb 28 - Feb 29
Form 4
+107.42%
53.14K
$78.26
-$1,855,466.34
102.62K
Jan 31
Form 4
+2.15%
1.51K
$79.02
-$100,276.38
71.64K
Dec 10
Form 4
-2.10%
-1.50K
$76.99
-$115,561.99
70.13K
Sep 12
Form 4
+2.14%
1.5K
$76.00
-$97,128.00
71.63K
Sep 10
Form 4
-4.81%
-1.49K
$76.90
-$114,196.50
29.4K
Jun 13
Form 4
+5.05%
1.49K
$78.12
-$101,087.28
30.89K
Jun 10
Form 4
-8.03%
-6.13K
$78.99
-$483,892.74
70.13K
Scheduled
Mar 13
Form 4
+8.74%
6.13K
$79.50
-$423,576.00
76.26K
Mar 10
Form 4
-15.62%
-12.98K
$79.96
-$1,038,225.31
70.13K
Scheduled
Mar 1
Form 4
+0.45%
376
$56.38
$21,199.07
83.11K
Feb 15
Form 4
+204.99%
55.61K
$84.02
-$1,491,270.98
82.74K
Jan 24
Form 4
-1.20%
-553.00
$85.33
-$47,187.49
45.56K
Scheduled
Dec 30
Form 4
+1.21%
553
$87.97
-$42,753.42
46.11K
Dec 10
Form 4
+6.63%
2.83K
$82.60
-$187,336.80
45.56K
Nov 10
Form 4
+1.32%
558
$65.28
-$31,399.68
42.73K
Sep 10
Form 4
+1.33%
554
$60.74
-$29,458.90
42.17K
Jun 10
Form 4
+0.84%
348
$52.13
$18,141.41
41.61K
Feb 15
Form 4
+11.05%
4.11K
$57.92
-$203,009.60
41.27K
Mar 10
Form 4
+120.39%
20.3K
—
—
37.16K
Jan 26
Form 4
+19.74%
2.78K
$67.32
-$156,182.40
16.86K
Nov 10
Form 4
+0.01%
1
$55.08
$55.08
14.08K
Aug 15
Form 4
+18.32%
2.18K
$60.39
-$104,748.49
14.08K
Feb 15 - Mar 10
Form 4
+343.17%
9.21K
—
—
11.9K
Jan 26
Form 4
∞
2.69K
$60.62
-$146,457.92
2.69K
Nov 10
Form 4
—
0
$62.88
-$1,982.71
0
Scheduled
Aug 15 - Aug 17
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Nov 10
Form 3
—
0
—
—
0
No matching records found

Sagimet Biosciences Inc. (SGMT) Snapshot price: $6.22

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
+47.45%
4.12K
—
—
12.79K
Jul 18
Form 3
—
0
—
—
0
No matching records found

Arcus Biosciences, Inc. (RCUS) Snapshot price: $14.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found